Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: medethix, inc. - maroon film-coated tablet containing: calcium ferrous citrate- 50mg; folic acid (granules)- 62.5mg; (eq to folic acid 300mcg); pink film-coated tablets containing: calcium carbonate- 1.25g (eq. to 500 mg elemental calcium); vitamin d3- 200 iu; magnesium hydroxide-216mg (eq. to 90 mg magnesium); zinc sulphate monohydrate- 11mg (eq. to 4 mg elemental zinc) - film-coated tablet - refer to generic name

United States - English - NLM (National Library of Medicine)

u.s. pharmaceutical corporation - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), calcium pantothenate (unii: 568e - ferrous fumarate 191.2 mg - description: each capsule contains: ferrous fumarate (anhydrous) ......191.1 mg polysaccharide iron complex... 135.9 mg (equivalent to about 125 mg of elemental iron) vitamin c (from proascorb c‡)....210 mg folic acid .....1 mg thiamine mononitrate (b1)...5 mg riboflavin (b2)....5 mg niacin (b3) . 20 mg d-calcium pantothenate (b5)..7 mg pyridoxine hcl (b6) ...25 mg biotin (b7)......300 mcg cyanocobalamin (b12) .. 10 mcg clinical pharmacology: integra plustm is unique in that it utilizes two (2) different forms of iron, i.e., ferrous fumarate and polysaccharide iron complex (as cell-contracted akaganèite), making available a total of 125 mg of elemental iron per capsule as follows: ferrous fumarate (anhydrous)    191.1 mg polysaccharide iron complex (pic)    135.9 mg subclinical b-group vitamin deficiencies have greatly increased in recent years, due to changes in dietetic habits, increase in the use of sugar, and the excessive milling of flour and cereals. with thiamine deficiencies in a healthy populous,

United States - English - NLM (National Library of Medicine)

u.s. pharmaceutical corporation - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), calcium pantothenate (unii: 568et80c3d) (pantothenic acid - u - ferrous fumarate 53.5 mg - description: each capsule contains: ferrous fumarate (elemental iron) . . . . . . . . . . 17.5 mg polysaccharideironcomplex(elementaliron).. 17.5mg (equivalent to about 35 mg of elemental iron) vitamin c (from proascorb c‡)    .    .    .    .    .    .    .    .    .    .    .    .    25 mg folicacid.............................. 1mg thiaminemononitrate(b1) ................ 2mg riboflavin(b2) .......................... 3mg niacin (b3, from proascorb c‡)    .    .    .    .    .    .    .    .    .    .    .    .    1.8 mg d-calciumpantothenate(b5)................ 5mg pyridoxinehci(b6) .................... 25mg biotin (b7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300 mcg cyanocobalamin(b12) ................ 12.5mcg copper(ascoppersulfate).................. 2mg magnesium(asmagnesiumsulfate) . . . . . . . . zinc(aszincsulfate).................... omega-3 fatty acids .    .    .    .    .    .    .    .    . ........... (derived from 310 mg fish oil) docosahexaenoic acid (dha) . ........... eic

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - iron polymaltose, quantity: 370 mg (equivalent: iron, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; macrogol 6000; crospovidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; iron oxide yellow; iron oxide red - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - conjugated estrogens, quantity: 0.625 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; carnauba wax; sucrose; hypromellose; lactose monohydrate; macrogol 400; hyprolose; calcium phosphate; powdered cellulose; titanium dioxide; propylene glycol; purified water; isopropyl alcohol; allura red ac aluminium lake; indigo carmine aluminium lake - oestrogens with or without progestogens should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman. 1 premarin is indicated as replacement therapy for oestrogen deficiency states associated with climacteric manifested by: a) moderate to severe vasomotor symptoms associated with oestrogen deficiency in natural and surgical menopause (sweating, hot flushes). periodic re-evaluation with a view to short term treatment is recommended. b) atrophic vaginitis. when prescribing solely for the treatment of symptoms of vaginal atrophy, topical vaginal products should be considered. there is no evidence that oestrogens are effective for anxiety or depression without associated vasomotor symptoms, and they should not be used to treat such conditions. 2. premarin is indicated for the prevention of postmenopausal osteoporosis in select patients. when prescribed solely for the prevention of postmenopausal osteoporosis, therapy should only be prescribed for women who are at high risk of osteoporosis and future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of osteoporosis. life style modifications and the risk benefit profile of premarin should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing. (see precautions and dosage and administration). 3. hypoestrogenic states e.g. female hypogonadism, primary ovarian failure or female castration. see boxed warning, particularly when considering premarin for long-term usage.

United States - English - NLM (National Library of Medicine)

trigen laboratories, inc. - ferrous sulfate (unii: 39r4tan1vt) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - ferrous cation 525 mg - for the treatment of iron deficiency and prevention of concomitant folic acid deficiency. for the prevention and treatment of iron deficiency and to supply a maintenance dosage of folic acid. contraindicated in patients with pernicious anemia and in the rare instance of hypersensitivity to folic acid. hemochromatosis and hemosiderosis are contraindications to iron therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - iron polymaltose 370mg equivalent to iron 100mg - film coated tablet - 100 mg - active: iron polymaltose 370mg equivalent to iron 100mg excipient: crospovidone macrogol 6000 magnesium stearate microcrystalline cellulose opadry maroon oy-s-36413 - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - folic acid; calcium pantothenate; ascorbic acid; riboflavine; niacinamide; ferrous sulfate; thiamine mononitrate; vitamin b12; pyridoxine hcl -

United States - English - NLM (National Library of Medicine)

meda pharmaceuticals - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - folic acid 1 mg

United States - English - NLM (National Library of Medicine)

us pharmaceutical corporation - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr) - folic acid 1 mg